Physician profile
Bo Sun
NPI 1881121416
$5,981.95
in general payments reported to CMS, 2019-2025
18 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $482 · 2022: $1,025 · 2023: $1,404 · 2024: $1,380 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,301.11 |
| Education | $173.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,397.57 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $1,335.01 | 2021-2025 | |
| Incyte Corporation | $1,010.38 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $579.14 | 2023-2024 | Vtama |
| Abbvie INC. | $406.86 | 2025 | |
| Pfizer INC. | $335.66 | 2021-2025 | |
| Galderma Laboratories, L.P. | $210.74 | 2025 | Nemluvio |
| Leo Pharma INC. | $209.66 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $136.43 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $113.78 | 2021-2025 | Ebglyss, Taltz |
| Novartis Pharmaceuticals Corporation | $66.36 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $55.18 | 2025 | Ycanth |
| Ucb, INC. | $27.88 | 2021 | |
| Janssen Scientific Affairs, LLC | $21.77 | 2021 | |
| Arcutis Biotherapeutics, INC. | $20.44 | 2024 | Zoryve |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $19.60 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.02 | 2025 | Jublia, Siliq, Cabtreo |
| Mallinckrodt Hospital Products INC. | $17.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bo Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.